Copertina

Toxin and Immunotoxin Based Therapeutic Approaches

In 1900, Paul Ehrlich, who was studying ricin and abrin at the time, discovered antibodies and paved the way for immunotherapy. After 120 years, Ehrlich’s insight into the therapeutic potential of immunotargeting is still a source of inspiration for many scientists. One of the most studied antibody-...

Descrizione completa

Salvato in:
Natura: Online
Lingua:inglese
Pubblicazione: MDPI - Multidisciplinary Digital Publishing Institute 2022
Soggetti:
3D structure
plant toxin
primary sequence
ribosome-inactivating protein
stenodactylin
toxic lectin
fusion proteins
ricin
pokeweed antiviral protein
COVID-19
SARS-CoV-2
antiviral agent
ribosome-inactivating proteins
monoclonal antibody
immunotoxin
antibody drug conjugate
immunoliposome
drug delivery
diphtheria toxin
DT3C
prostate cancer
targeted toxins
epidermal growth factor
epidermal growth factor receptor
Pseudomonas Exotoxin A
patient-derived glioblastoma cell lines
Chenopodium quinoa wild
quinoin
temozolomide
Glypican-3
hepatocellular carcinoma
humanized YP7
new recombinant immunotoxin
kirkiin
sugar specificity
cancer therapy
n/a
thema EDItEUR::N History and Archaeology::NH History
thema EDItEUR::J Society and Social Sciences::JB Society and culture: general::JBF Social and ethical issues
Accesso online:ONIX_20220224_9783036530659_132
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi: Toxin and Immunotoxin Based Therapeutic Approaches

Documenti analoghi